Parameters associated with outcomes in pretreated MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Subgroup analysis of a prospective cohort.

Raphaël Colle,Marine Cachanado,Alexandra Rousseau,Magali Svrcek,Yves Menu,Romain Cohen,Thierry André

Parameters associated with outcomes in pretreated MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Subgroup analysis of a prospective cohort.

2021

Raphaël Colle
Marine Cachanado
Alexandra Rousseau
Magali Svrcek
Yves Menu
Romain Cohen
Thierry André

3580Background: Immune checkpoint inhibitors (ICI) have demonstrated efficacy in patients (pts) with MSI/dMMR mCRC. We aimed to evaluate clinical, pathological and molecular factors associated with...

Keywords:

Medicine
Internal medicine
Pathological
in patient
Oncology
Colorectal cancer
Subgroup analysis
Prospective cohort study
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations